The comprehensive treatment of nasolacrimal duct obstruction and stenosis is FCI Ophthalmics’ core business. As a world leader in the R&D of lacrimal devices we provide bicanalicular and monocalicular stents and tubes.
FCI is proud to present the Nunchaku®
FCI Nunchaku® is a pushed bicanalicular intubation stent that acts like a conformer, allowing tears to be drained by capillarity. The metallic guides are located inside the lumen, not as an extension of the stent as in conventional intubation sets. Therefore, no nasal retrieval is needed.
Flexibility
Offering a number of lacrimal stents and tubes for a wide range of bicanalicular and monocanalicular intubations.
Consistency
Enabling you to perform complicated canalicular repair with confidence with the Mini Monoka, Ritleng®, and Self-Threading Monoka.
Capability
Enhancing your surgical approach with innovative devices such as StopLoss™ Jones Tubes, OphtaCath®, and Nunchaku®.
From a technical perspective, pushed nasolacrimal intubation is much simpler than the traditional pulled types of nasolacrimal intubation. The anesthetic procedure required is the same as that for a late probing procedure, but the functional results are better.
Bernard Fayet - designer of the Masterka® and Monoka®
J Fr Ophtalmol., November 2011
To learn more about self-retaining stents, lacrimal tubes, and other products developed for the treatment of nasolacrimal duct obstruction, contact FCI Ophthalmics.
Questions about our Lacrimal products?
FCI Ophthalmics
[email protected]
800-932-4202
781-826-9060